As expected, miR‐193a‐3p overexpression reduced PTEN expression and increased phosphorylated Akt (p‐Akt) levels in ESCC cells (Figure 4D,F), while miR‐193a‐3p inhibited increased PTEN expression and decreased p‐Akt levels in ESCC cells (Figure 4E,G). The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.